Clinical White Papers and Case Studies
-
Investigating Enrollment Reliability With The Longboat Platform
5/17/2024
This overview highlights real research programs at various stages of the recruitment process and demonstrates the impact of Advarra’s Longboat Platform across multiple therapeutic areas and sponsors.
-
Citeline Pharma R&D Review 2024: Pleasant Weather Ahead
5/16/2024
The pharma R&D environment continued its warming trend in 2024, with pipeline drugs rising 7.2% to hit a new high of 22,825. Oncology drugs accounted for 38% of all new drug candidates, while neurologicals came in second with a 12.7% share. Pfizer led the pack with 32 new candidates in the pipeline.
-
Driving ROI: The Business Case For A Comprehensive Financial Transformation Solution
5/15/2024
Explore how utilizing comprehensive financial transformation solutions can address budgeting and site payment challenges, drive value across the study lifecycle, and realize operational and business benefits.
-
Optimizing Recruitment For Urgently Needed Vaccine
5/15/2024
Uncover how Citeline Connect helped a late-stage biotech sponsor expedite enrollment of a diverse population of eligible patients impacted by monkeypox for a large Phase 1 and Phase 2 trial of a next-generation vaccine.
-
Deal-Making Volume Slowed In 2023
5/15/2024
This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.
-
CRO Leverages Integrated Central IBC Partnership To Initiate Sites
5/15/2024
Learn how a CRO was able to accelerate review times so COVID-19 vaccine trial sites could progress through site selection, IRB/IBC submission, approval, drug shipment, and complete site initiation visits in record time.
-
Earlier Disease Detection Study Utilizes EDC
5/15/2024
Leveraging hyperspectral imaging and AI-driven analysis, Optina Diagnostics aims to revolutionize Alzheimer's diagnosis, offering hope for earlier intervention and improved outcomes.
-
Helping To Ensure The Success Of A Phase 3 Vaccine Trial
5/14/2024
With Longboat, this pharma company trained all staff across trial sites, ensuring treatment for all 20,000 patients with real-time training reports.
-
Ensuring Success In A Rare Neuromuscular Disease Study
5/14/2024
Uncover how a biotechnology company experienced recruitment and compliance success after utilizing the Longboat Platform to provide training for every staff member at every trial site.
-
Examining A Phase 1 COVID-19 Clinical Trial
5/10/2024
Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.